Magnetic hyperthermia with ε-Fe₂O₃ nanoparticles

Area of Science:

• Materials Science
• Biomedical Engineering
• Nanotechnology

Background:

• Biocompatibility limits magnetic hyperthermia agents to magnetite (Fe3O4) and maghemite (γ-Fe2O3).
• ε-iron oxide (ε-Fe2O3) possesses unique magnetic properties, specifically giant coercivity, yet remains unexplored for hyperthermia.

Purpose of the Study:

• To evaluate the heating efficacy of ε-Fe2O3 nanoparticles compared to γ-Fe2O3 nanoparticles.
• To investigate the influence of frequency, amplitude, and media viscosity on nanoparticle heating.
• To assess the biocompatibility and cellular uptake of ε-Fe2O3 nanoparticles.

Main Methods:

• Synthesized ε-Fe2O3 and γ-Fe2O3 nanoparticles of similar size (~20 nm).
• Measured heating power across a range of frequencies (20-900 kHz) and amplitudes.
• Assessed nanoparticle performance in media with varying viscosity, mimicking cell cytoplasm.
• Conducted cell culture experiments to determine toxicity and internalization rates.

Main Results:

• ε-Fe2O3 nanoparticles demonstrated optimal heating in the low-frequency range (20-100 kHz) and low-viscosity media.
• γ-Fe2O3 nanoparticles were more effective at higher frequencies (400-900 kHz).
• ε-Fe2O3 nanoparticles exhibited no significant toxicity and high cellular uptake across tested concentrations.

Conclusions:

• ε-Fe2O3 nanoparticles offer potential for switchable magnetic hyperthermia due to their distinct frequency-dependent heating.
• While slightly less effective than γ-Fe2O3 for current applications, ε-Fe2O3's unique properties warrant further investigation.
• These findings expand the scope of magnetic iron oxides for hyperthermia therapies.